Matthew Kurian, Assistant Professor of Medicine at the University of Kentucky College of Medicine, shared a post on LinkedIn:
“Grateful for the opportunity to speak at this important HER2 Cancers program hosted by the Innovative Healthcare Institute and Cincinnati Cancer Advisors.
It was energizing to collaborate with a truly multidisciplinary group—oncologists, radiation oncologists, pathologists, nurses, pharmacists, and industry partners—as we tackled the controversies and challenges in HER2 testing and treatment across tumor types.
I was excited to share the latest breast cancer HER2 updates, from HER2-positive to HER2-low and ultralow, and discuss how these evolving definitions are reshaping precision oncology and patient care.
Events like this remind me why collaboration is so critical to advancing cancer care in our region and beyond!”
More posts featuring Matthew Kurian.
